Display options
Share it on

Int J Cell Biol. 2009;2009:417197. doi: 10.1155/2009/417197. Epub 2009 Oct 07.

Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells.

International journal of cell biology

Nadia Gabellini, Valentina Masola

Affiliations

  1. Department of Biological Chemistry, University of Padova, 35121 Padova, Italy.

PMID: 20111625 PMCID: PMC2809431 DOI: 10.1155/2009/417197

Abstract

The LGI1 gene was suggested to function as tumor suppressor for its ability to reduce malignant features of glioblastoma cells. In support to this proposal were the findings that overexpression of LGI1 in neuroblastoma cells inhibited proliferation and induced apoptosis. In this study we performed stable LGI1 expression in HeLa cells to examine whether the noxious effect of LGI1 might be extended to cancer cells of diverse origin. HeLa cell clones stably expressing LGI1 exhibited a significant impairment of proliferation and a consistent increase of cell death when compared with control cells lacking expression of LGI1. Expression of LGI1 increased the activity of apoptosis effectors caspase-3/7; furthermore it downregulated the antiapoptotic BCL2 gene and upregulated the proapoptotic BAX gene expression, suggesting that the cause of HeLa cells death might be an increased susceptibility to apoptosis induced by LGI1. The results suggested that LGI1 is capable to restrain growth and survival of adenocarcinoma cells such as HeLa.

References

  1. J Virol. 2005 Jul;79(14):9296-300 - PubMed
  2. Cell. 1993 Nov 5;75(3):495-505 - PubMed
  3. Science. 2006 Sep 22;313(5794):1792-5 - PubMed
  4. Oncogene. 2001 Jan 11;20(2):240-51 - PubMed
  5. Oncogene. 1998 Dec 3;17(22):2873-81 - PubMed
  6. J Invest Dermatol. 2001 Aug;117(2):333-40 - PubMed
  7. Nat Genet. 2002 Mar;30(3):335-41 - PubMed
  8. Int J Cancer. 2008 Mar 15;122(6):1303-10 - PubMed
  9. Oncogene. 2003 Jun 26;22(26):3985-91 - PubMed
  10. Br J Cancer. 1997;76(7):935-8 - PubMed
  11. Biochem Biophys Res Commun. 2003 Dec 19;312(3):585-91 - PubMed
  12. Nat Rev Cancer. 2002 Sep;2(9):647-56 - PubMed
  13. Biochem Soc Trans. 2004 Jun;32(Pt3):480-4 - PubMed
  14. Clin Cancer Res. 1999 Feb;5(2):319-24 - PubMed
  15. Trends Biochem Sci. 1994 Oct;19(10):415-21 - PubMed
  16. Neuron. 2006 Mar 2;49(5):697-706 - PubMed
  17. Oncogene. 1996 Mar 7;12(5):1055-62 - PubMed
  18. Hum Mol Genet. 2005 Jun 15;14(12):1613-20 - PubMed
  19. Trends Biochem Sci. 2002 Sep;27(9):441-4 - PubMed
  20. Mamm Genome. 2007 May;18(5):328-37 - PubMed
  21. Oncol Rep. 2008 Jul;20(1):203-10 - PubMed
  22. Science. 1989 Feb 17;243(4893):934-7 - PubMed
  23. Hum Mol Genet. 2002 May 1;11(9):1119-28 - PubMed
  24. J Cell Physiol. 2006 Jun;207(3):711-21 - PubMed
  25. Eur J Biochem. 2001 Mar;268(5):1352-62 - PubMed
  26. J Virol. 1988 May;62(5):1640-6 - PubMed
  27. J Biol Chem. 2004 May 28;279(22):23151-7 - PubMed
  28. Hum Mol Genet. 2002 Jul 15;11(15):1757-62 - PubMed
  29. Cell. 1995 Jan 27;80(2):293-9 - PubMed
  30. Curr Opin Neurobiol. 2001 Jun;11(3):297-305 - PubMed

Publication Types